Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 60, Issue 1 , Pages 32-40 , January 2007

Incidence, mortality and survival in cutaneous melanoma

Received 16 March 2006 ,Accepted 2 May 2006.

References 

  1. Statistical Information Team Cancer Research UK. Information Resource Centre. Available from: <www.Cancerresearchuk.org/cancerstats>; 2005.
  2. Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure. Arch Dermatol. 1996;132:444–459
  3. Gilchrest BA, Eller MS, Geller AC, et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341–1348
  4. Armstong BK, Kricker A. How much melanoma is caused by sun?. Melanoma Res. 1993;3:395–401
  5. Garland CF, Garland FC, Gorham ED. Epidemiologic evidence for the different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann Epidemiol. 2003;13:395–404
  6. Tucker MA, Goldstein AM. Melanoma etiology: where are we?. Oncogene. 2003;22:3042–3052
  7. Marks R, Whiteman D. Sunburn and melanoma: how strong is the evidence?. BMJ. 1994;308:75
  8. Zanetti R, Francesschi S, Rosso S, et al. Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer. 1992;28:1172–1176
  9. Khalat M, Vail A, Parkin M, et al. Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. Am J Epidemiol. 1992;135:1103–1113
  10. Holman CA, Armstrong BK, Heenan PJ, et al. The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent results. Cancer Res. 1986;102:18–37
  11. Elwood JM, Gallagher RP, Hill GB, et al. Cutaneous melanoma in relation to intermittent and constant sun exposure – the Western Canada Melanoma Study. Int J Cancer. 1985;35:427–433
  12. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2005;14:562–566
  13. Pion IA, Rigel DS, Garfinkel L, et al. Occupation and the risk of malignant melanoma. Cancer. 1995;75(Suppl. 2):637–644
  14. English D. The Cancer Council Victoria, Australia. Primary prevention of melanoma in Australia. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 074].
  15. Hall C. Holiday at home or abroad?. Financial mail. July 25, 2005;Available from: http://www.thisismoney.co.uk/money-savers/article.html?in_article_id=402505&in_page_id=5
  16. Swerdlow AJ, dos Santos Silva I, Doll R. Cancer incidence and mortality in England and Wales: trends and risk factors. Oxford: Oxford University Press; 2001;
  17. Miles A, Waller J, Hiom S, et al. Skin cancer knowledge and preventive behaviour in a British population representative sample. Health Educ Res. 2005;20(5):579–585
  18. Davis N. Modern concepts of melanoma and its management. Ann Plast Surg. 1978;1:628–629
  19. Coory M, Baade P, Aitkin J, et al. Trends for in-situ and invasive melanoma in Queensland, Australia, 1982–2002. Cancer Causes Control. 2006;17(1):21–27
  20. The World Health Organization . The World Health Organization recommends that no person under 18 should use a sunbed. WHO Media Centre; March 17, 2005;Available from: www.who.int/mediacentre/news/notes/np07/en/
  21. Quinn M, Babb P, Brock A, et al. Cancer trends in England and Wales 1950–1999. Vol. SMPS no. 66 TSO; 2001;
  22. Office for National Statistics . Cancer Statistics registrations: registrations of cancer diagnosed in 2002, England. Series MB1 no.33 London: National Statistics; 2005;Available from: www.statistics.gov.uk/downloads/theme_health/MBI_33/MBI_33revised.pdf
  23. In:  Ries LAG,  Eisner MP,  Kosary CL,  Hankey BF,  Miller BA,  Clegg L,  Mariotto A,  Feuer EJ,  Edwards BK editor. SEER Cancer Statistics Review, 1975–2002. Bethesda, MD: National Cancer Institute; November 2004;http://seer.cancer.gov/csr/1975_2002/[based on November 2004 SEER data submission, posted to the SEER web site 2005]
  24. Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294:1647–1654
  25. Australian Institute of Health and Welfare , de Looper M, Bhatia K. Australian Health Trends 2001. AIHW Cat. no. PHE 24 Canberra: AIHW; 2001;Available from: http://www.aihw.gov.au/publications/phe/aht01/index.html
  26. de Vries E, Tyczynski J, Parkin D. Cutaneous malignant melanoma in Europe. ENCR. 2003;4:1–4
  27. MacKie R. Melanoma incidence in the west of Scotland over the 25 years. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 039].
  28. MacKie R, Bray C, Hole D, et al. Incidence and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002 Aug 24;360:587–591
  29. MacKie R, Bray C, Hole D, et al. The changing incidence of cutaneous melanoma in the west of Scotland and Queensland 1982–2001, an intercontinental comparison. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract BE3-1].
  30. Balch CM, Soong SJ, Milton GW, et al. Changing trends in cutaneous melanoma over a quarter of a century in Alabama, USA and New South Wales, Australia. Cancer. 1983;52:1748–1753
  31. Bulliard J-L, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969–1993. Int J Epidemiol. 2000;29:416–423
  32. Kwan TY, Belke TW, Enta T. Sex differences in the anatomical distribution of melanocytic naevi in Canadian Hutterite children. J Cutan Med Surg. 2000;4:58–62
  33. Giles GG, Armstrong BK, Burton RC, et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996;312:1121–1125
  34. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950–2002 and their implications for melanoma control. Aust NZ J Public Health. 2005;29:383–386
  35. Hall HI, Miller DR, Annas GD, et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 1999;40:35–42
  36. Office for National Statistics. Mortality statistics: cause. England and Wales 2001. Series DH2 no. 28 Available from: National Statistics website at www.statistics.gov.uk/statbase/product.asp?vInk=618.
  37. Coleman MP, Babb PO, Damiecki P, et al. Cancer survival trends in England and Wales. 1971–1995. Deprivation and NHS region. London: The Stationary Office; 1999;
  38. Coleman MP, Rachet B, Woods LM. Trends in socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer. 2004;90(7):1367–1373
  39. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005 Mar–Apr;55(2):74–108
  40. McLeod GR, Davis N, Sober AJ. History of melanoma. In:  Balch CM,  Houghton AN,  Sober AJ,  Soong S editor. Cutaneous melanoma. 4th ed.. St Louis, Missouri: QMP; 2003;p. 9–10
  41. Weinstock MA. Sun protection and early detection: do we have the balance right? In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 114].
  42. Lim HW, Gilchrest BA, Cooper KD, et al. Sunlight, tanning booths, and vitamin D. Am Acad Dermatol. 2005;52:868–876
  43. Halpern A. Primary prevention of skin cancer in the United States. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 075].
  44. Diffey BL. A quantitative estimate of melanoma mortality from ultraviolet A sunbed use in the UK. Br J Dermatol. 2003;149(3):578–581
  45. Dennis LK. Analysis of the melanoma epidemic, both apparent and real. Data from the 1973 through 1994 surveillance, epidemiology and end results program registry. Arch Dermatol. 1999;134:275–280
  46. Severi G, Giles GG, Robertson C, et al. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer. 2000;82:1887–1891
  47. Chamberlain AJ, Fritschi L, Giles GG, et al. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138:609–614
  48. Richardson B, Price A, Wagner M, et al. Investigation of female survival benefit in metastatic melanoma. Br J Cancer. 1999;80:2025–2033
  49. Dennis L, Ritchie J, VanBeek M, et al. Tanning attitudes and beliefs among sorority and fraternity students. In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract BE3-5].
  50. Expert Group on climate change and health in the UK . Health effects of climate change in the UK. London: Department of Health; 2001;Available from: www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4007935&chk=aPZEuj
  51. Austoker J. Cancer prevention in primary care: melanoma: prevention and early diagnosis. BMJ. 1994;308:1682–1686
  52. American Cancer Society . Overview: skin cancer – melanoma, how many people get melanoma skin cancer?. Available from: http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_How_many_people_get_melanoma_skin_cancer_50.asp?sitearea=2006;
  53. US Preventive Services Taskforce . Guide to clinical preventive services. 2nd ed.. Baltimore: Williams and Williams; 1996;
  54. Diffey B. Should we be surprised that sunscreens appear not to be protective in melanoma? In: Presented at the sixth World Congress on Melanoma. Vancouver, BC; September 2005 [Abstract 121].
  55. Garland C, Garland F, Gorham E. Rising trends in melanoma: an hypothesis concerning sunscreen effectiveness. Ann Epidemiol. 1993;3:103–110
  56. Pacifico MD, Grover R, Sanders R. Use of an early-detection strategy to improve disease control in melanoma patients. Br J Plast Surg. 2004 Mar;57(2):105–111
  57. Carli P, Nardini P, Crocetti E, et al. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study. Melanoma Res. 2004 Oct;14(5):403–407
  58. Helfand M, Mahon SM, Eden KB, et al. Screening for skin cancer. Am J Prev Med. 2001;20:47–58
  59. Rager EL, Bridgeford EP, Ollila DW. Cutaneous melanoma: update on prevention, screening, diagnosis and treatment. Am Fam Physician. 2005;72:269–276
  60. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base no. 5, version 2.0 Lyon, France: IARC Press; 2004;
  61. Sant M, Aareleid T, Berrino , et al. EUROCARE-3: survival of cancer patients diagnosed 1990–1994 – results and commentary. Ann Oncol. 2003;14(Suppl. 5):v61–v118

PII: S1748-6815(06)00385-8

doi: 10.1016/j.bjps.2006.05.008

Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 60, Issue 1 , Pages 32-40 , January 2007

Article Tools

* Image Usage & Resolution